Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining 0.27% today. In the last week its performance is 1.22%, and 4.23% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 47, so today’s gain of 0.27% is a significant step towards its target price. The GAP today is therefore 0.87%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 105624.04, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 8.60%.
At the current price of 43.87, it has a dividend yield of 5.06%, and its target price is 47. This is with a profit margin of 2.50%, and total debt/equity of 6.05. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 135.4, as well as a forward P/E of 16.78.
With a current EPS of 0.32, and a forecasted EPS growth for next year at 14.05%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 0.60%.
Performance for the year is 9.32%. Since its IPO date on 7/9/1986, the total performance to date is 13.66%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 4021000, while its average volume is 3483.36. Whilst the total gain today was 0.27%, it did have a day high of -0.66%.
Volatility for this week has been at 1.05%, and 1.54% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 24.90%, while the 52-week-high has reached -0.66%.
Looking at its return of investments, which is 41.40%, and its return on assets is 1.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 7.50%. With a sales growth of 10.80% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 5.61, and has a current ratio of 1.1 and 0.8 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 225.67, and the P/S is 3.34, along with a P/B of 29.25. Meanwhile it has a p/cash of 18.24.